Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

Diabetes Care

Volumn 35, Issue 8, 2012, Pages 1663-1668

  Chalk, Daniel ^a   Pitt, Martin ^a   Vaidya, Bijay ^b   Stein, Ken ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; RETINA MACULOPATHY; RETINAL SCREENING; UNITED KINGDOM; VISION TEST; VISUAL IMPAIRMENT;

DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MASS SCREENING; TIME FACTORS;

EID: 84864383699     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2282     Document Type: Article

References (29)

1. Davies R, Roderick P, Canning C, Brailsford S. The evaluation of screening policies for diabetic retinopathy using simulation. Diabet Med 2002;19:762-770 (Pubitemid 35013856)
2. Fong DS, Aiello L, Gardner TW, et al.; American Diabetes Association. Retinopathy in diabetes. Diabetes Care 2004;27 (Suppl. 1):S84-S87 (Pubitemid 38197476)
3. Lopez-Bastida J, Cabrera-Lopez F, Serrano- Aguilar P. Sensitivity and specificity of digital retinal imaging for screening diabetic retinopathy. Diabet Med 2007;24:403-407 (Pubitemid 46452393)
4. NICE. Management of type 2 diabetes (retinopathy - screening and early management) [article online], 2002. Available from http://www.nice.org.uk/ nicemedia/ pdf/diabetesretinopathyguideline.pdf. Accessed 12 January 2012
5. National Screening Programme for Diabetic Retinopathy Enriched Grading Form [article online], 2010. Available from: http://www. retinalscreening.nhs. uk/userFiles/File/ Enriched%20Grading%20form%20Version% 2021%2003%2010.pdf. Accessed 12 January 2012
6. Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009;32:2307-2313
7. Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195-200 (Pubitemid 36126218)
8. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
9. Zavrelova H, Hoekstra T, Alssema M, et al. Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system West- Friesland, the Netherlands. Diabetes Care 2011;34:867-872
10. Kytö JP, Harjutsalo V, Forsblom C, Hietala K, Summanen PA, Groop PH; FinnDiane Study Group. Decline in the cumulative incidence of severe diabetic retinopathy in patientswith type 1 diabetes. Diabetes Care 2011;34:2005-2007
11. Davies R, Brailsford S, Roderick P, Canning C, Crabbe D. Using simulationmodelling for evaluating screening services for diabetic retinopathy. J Oper Res Soc 2000;51:476-484 (Pubitemid 30589575)
12. Klein R, Klein BE, Moss SE, Davis MD, De Mets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmology 1989; 107:244-249 (Pubitemid 19055345)
13. McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin Experiment Ophthalmol 2003;31:397-402 (Pubitemid 37461205)
14. Younis N, Broadbent DM, Harding SP, Vora JP. Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 2003; 20:758-765 (Pubitemid 41701472)
15. Olafsdóttir E, Stefánsson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 2007;91:1599-1601 (Pubitemid 350207380)
16. Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249-256
17. González ELM, Johansson S, Wallander M-A, Rodríguez LAG. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009;63:332-336
18. Diabetes in the UK 2010: key statistics on diabetes [article online], 2010. Available from http://www.diabetes.org.uk/Documents/ Reports/Diabetes-in- the-UK-2010.pdf. Accessed 12 January 2012
19. Cusick M, Meleth AD, Agrón E, et al.; Early Treatment Diabetc Retinopathy Study Research Group. Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 2005;28:617-625 (Pubitemid 40315322)
20. Diabetic Retinopathy Screening Programme Quality Assurance Standards Version NHS. 1.2 Release 7 [article online], 2011. Available from http://www.retinalscreening.nhs. uk/userFiles/File/ Phase%201%20Revised%20Quality%20Assurance%20Standards% 2029th%20June%202011%20Release% 207%20v1%202%20(4)%20sc.pdf. Accessed 12 January 2012
21. Chew EY, Ferris FL 3rd, Csaky KG, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology 2003;110:1683-1689 (Pubitemid 37025423)
22. Winocour PH. Effective diabetes care: a need for realistic targets. BMJ 2002;324: 1577-1580 (Pubitemid 34713140)
23. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 2001;24:1815-1820 (Pubitemid 33716488)
24. Kavanagh DJGS, Gooley S, Wilson PH. Prediction of adherence and control in diabetes. J Behav Med 1993;16:509-522 (Pubitemid 23304489)
25. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-163 (Pubitemid 32156199)
26. Davis MD, Fisher MR, Gangnon RE, et al. Risk factors for high risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Study Report 18. Invest Ophthalmol Vis Sci 1998;39:233-252 (Pubitemid 28093859)
27. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Opthalmol 1998;116:297-303
28. Porta M, Bandello F. Diabetic retinopathy: a clinical update. Diabetologia 2002; 45:1617-1634 (Pubitemid 35478131)
29. Aspelund T, Thornórisdóttir O, Ólafsdottir E, et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 2011;54:2525-2532